A group of medical researchers has just exposed an alarming surge in deaths among Covid-vaccinated patients admitted to hospital intensive care units (ICU).
The researchers, affiliated with several renowned academic medical centers across India, identified a death spike in non-Covid ICU patients.
The study, led by Dr. Amarja A. Havaldar of the St. John’s Medical College Hospital Bengaluru, sought to investigate the timing of the Covid vaccination and admission diagnosis and their effect on ICU mortality.
The time from vaccination can help identify adverse events directly related to vaccination.
Dr. Havaldar and her team conducted this retrospective cohort study across four medical centers in India.
Participants for this study were vaccinated patients (first or second dose) who were admitted with non-Covid illness to the intensive care unit (ICU).
The study was designed to categorize patients based on the time interval from vaccination as ≤42 days or >42 days.
The primary endpoint for this investigation was to identify ICU mortality rates.
The secondary outcomes were the length of ICU stay and duration of mechanical ventilation.
The study’s outcomes were incredibly troubling, however.
Many of the patients developed thromboembolic events (blood clots) and neuromuscular (nervous system and muscles) diseases requiring ICU admission post-Covid vaccination.
Moreover, Havaldar and colleagues discovered significantly higher mortality in the age groups 66 and over and 35 years and under when admitted within 42 days of Covid vaccination.
Patients admitted with cerebrovascular (blood flow to the brain) diseases also had higher mortality.
The results of the peer-reviewed study were published in the prestigious Cureus journal.
The study team designed the protocol to include 175 ICU patients.
The mean average participant age was 53.49 (15.89) years.
61.14% of the participants were males.
Overall, the ICU mortality rate among this cohort (vaccinated and hospitalized in ICU) equaled 24.57% (18.38% to 31.63%).
Havaldar and colleagues report the following seen in the patient group:
| Disease Event Post COVID Vax | % |
| Thromboembolic events such as acute coronary syndrome (ACS) | 7.43% |
| Cerebrovascular accident (CVA) | 7.43% |
| Mesenteric ischemia | 1.14% |
Six patients – or 3.43% – developed a deadly neuromuscular illness.
The authors report the mortality was higher in patients 66 years and older at the time they were admitted to ICU.
The second highest rate of mortality was in the group aged 35 and younger.
The majority of the patients were admitted to the ICU within 42 days of vaccination, raising major concerns among the researchers.
The mortality was higher in cerebrovascular disorders and was clinically significant.
Time from vaccination to ICU admission was significantly lower in non-survivors compared to survivors.
Although statistically not significant, the proportion of mortality (30.14%) was higher in patients admitted within 42 days post-vaccination as compared to those admitted after 42 days of vaccination (20.59%).
In this study, the authors point out that “neuromuscular illness is possibly related to vaccination; however, causality could not be determined.”
Additionally, “time from vaccination alone was the significant factor in logistic regression after adjusting for covariates, including APACHE II.”
The damning findings from the study align with previous studies that found surges in hospital admissions among the Covid-vaccinated.
As THAIMBC News recently reported, a bombshell new study from leading American researchers found that hospitals treated far more people for mRNA “vaccine” adverse events than unvaccinated patients with Covid infections.
The study, led by Drs. Johannes D Knapp and Aditi Bhargava, PhD, was conducted by researchers affiliated with the University of California, San Francisco (UCSF) and data firm Aseesa Inc.
The researchers sought to investigate the differences in COVID-19 outcomes based on gender.
However, the study found that the mRNA vaccines developed by Pfizer-BioNTech and Moderna led to a higher adverse event rate than COVID-19 itself as measured by hospitalization.
Specifically, hospitals treated mRNA vaccine-injured people at a rate 3.8X higher than unvaccinated patients with Covid infections.
